Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 8

ash.confex.com

Oral and Poster Abstracts Oral 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Hodgkin Lymphoma Clinical Trials Biological, Therapies, Immunotherapy Pamela Allen, MD1, Qing C Chen, MD, PhD2*, Xinyan Lu, MD2*, Kaitlyn O'Shea, PhD3*, Joan Chmiel, PhD4*, Madina Sukhanova, PhD2*, Liron Barnea Slonim, MD2*, Hatice Savas, MD5*, Eric Mou, MD6,...

  • Exciting additional f/u data of sequential Pembro followed by AVD for front line cHL, though only 30 patients treated, CMR after second cycle of AVD was 100%, the PFS and OS at median follow up of 33 months was 100%!